Latest Share Registry News

American West Metals has launched an offer of over 104 million new options to select investors and advisors, potentially raising $6.28 million upon exercise. The move aims to enhance liquidity and support ongoing exploration projects.

Domino’s Pizza Enterprises has explained the late filing of a director interest notice as an administrative oversight, reaffirming its compliance procedures amid ASX scrutiny.

Silver Mines Limited progresses regulatory approvals for its flagship Bowdens Silver Project in NSW while acquiring promising US assets, enhancing its exploration pipeline with minimal upfront costs.

Cosmos Exploration progresses its exclusive option to acquire EAU Lithium, advancing lithium extraction technology testing in Bolivia’s high-magnesium brines with promising initial results.

Alicanto Minerals is actively assessing new copper, gold, and silver projects while preparing for a key summer field program in Sweden, supported by a solid cash position of $2.64 million.

Rio Tinto Limited has announced a fully franked interim dividend of USD 1.48 per share for the six months ending June 2025, with multiple currency payment options and a Dividend Reinvestment Plan available.

Vintage Energy has addressed an ASX compliance issue related to the timing of its May 2025 securities issuance, confirming reliance on its placement capacities to maintain regulatory adherence.

Ryder Capital has halted its Dividend Reinvestment Plan, opting to pay shareholders cash dividends instead. The move raises questions about the company’s strategic direction and shareholder returns.

PointsBet Holdings has dismissed allegations from Betr Entertainment regarding vote exclusion in its recent Scheme of Arrangement meeting, confirming the scheme’s approval and setting the stage for a crucial court hearing.

Australian Strategic Materials Limited (ASM) has announced an underwritten Share Purchase Plan to raise approximately A$3 million, offering eligible shareholders a 20% discount on new shares. The plan opens on 19 June and closes on 17 July 2025.

Artrya Limited has submitted a pivotal FDA 510(k) application for its AI-powered Salix® Coronary Plaque module, aiming for clearance in Q3 2025 and a lucrative US commercial launch.

AdAlta Limited has successfully placed the remaining shortfall in its renounceable rights issue, raising a total of $1.3 million to advance its cellular immunotherapy pipeline. The company also addressed an administrative breach involving director share allocations, ensuring compliance with ASX rules.